Cancer & Metabolism

Papers
(The TQCC of Cancer & Metabolism is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
A role of arginase-1-expressing myeloid cells in cachexia117
FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma55
The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin’s lymphoma—an observational study55
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition42
Gut microbiota-derived indole-3-propionic acid promotes lymph node metastasis in gastric cancer via the aryl-hydrocarbon receptor signaling pathway40
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation31
Measurement of mitochondria amount and clearance using flow cytometry: effect of mitophagy inhibitors in leukemia cells29
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival28
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response28
Ketomimetic nutrients remodel the glycocalyx and trigger a metabolic defense in breast cancer cells27
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma27
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer25
Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells25
Transcriptome-driven constraint-based modelling reveals metabolic targets for ovarian cancer24
Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes24
In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T23
Circulating metabolome landscape in Lynch syndrome23
Autofluorescence imaging of endogenous metabolic cofactors in response to cytokine stimulation of classically activated macrophages21
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells21
Steatohepatitis-induced vascular niche alterations promote melanoma metastasis19
Dexmedetomidine promotes colorectal cancer progression mediated by gamma-aminobutyric acid signaling18
POU2F1 drives cholesterol biosynthesis and lipid remodeling through the DHCR24/ELOVL2 axis in endometrial cancer17
CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function16
CYP8B1 suppressed by Ras/ERK leads to cholesterol accumulation and bile acids reduction and facilitates hepatic tumorigenesis16
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors14
Fasting-mimicking diet counteracts gut microbial dysbiosis in experimental lynch syndrome13
Pharmacological inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) imparts selective leukemia cell death13
Disrupting Na+ ion homeostasis and Na+/K+ ATPase activity in breast cancer cells directly modulates glycolysis in vitro and in vivo13
VAV2 drives glycolytic reprogramming in esophageal squamous cell carcinoma via EIF3F-mediated MTA1 deubiquitination13
Sustained reductions in valine and isoleucine mediate anti-cancer pharmacological effects of inhibiting amino acid transporter LAT1 in cancer cells13
Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging13
PFKFB4 promotes M2 polarization of tumor-associated macrophages through aerobic glycolysis-mediated modification of histone H3K18 lactylation in hepatocellular carcinoma12
BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells12
Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinoma12
Correction: STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma12
Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles12
Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states12
The integration of single-cell and metabolomics reveals the increase of oxidative phosphorylation during the liver metastasis of colorectal cancer11
STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma11
Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 111
Breast cancer cells that preferentially metastasize to lung or bone are more glycolytic, synthesize serine at greater rates, and consume less ATP and NADPH than parent MDA-MB-231 cells11
Lactate metabolism in clonal plasma cells and its therapeutic implications in multiple myeloma patients with elevated serum LDH levels11
0.34645199775696